Interestingly, our analysis also reveals a potential effect of MEK inhibitors in reverting the COVID-19 CS, which is supported by in vitro data that confirms the anti-inflammatory properties of these compounds. This evidence concerns the gene MAP2K7 and Cowden syndrome 1.